CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
50.47
-0.01 (-0.02%)
Nov 13, 2026, 1:48 PM EST - Market open
CONMED Revenue
CONMED had revenue of $335.56M in the quarter ending September 30, 2026, a decrease of -0.70%. This brings the company's total for the last twelve months to $1.37B, up 1.62% year-over-year. In the year 2025, CONMED had annual revenue of $1.37B with 5.18% growth. That makes CONMED the 6,356th largest company in the world by revenue and 1,584th in the United States.
Revenue (ttm)
$1.37B
Revenue Growth
+1.62%
P/S Ratio
1.10
Revenue / Employee
$351,099
Employees
3,900
Market Cap
1.50B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full CONMED breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.37B | 67.71M | 5.18% |
| Dec 31, 2024 | 1.31B | 62.27M | 5.00% |
| Dec 31, 2023 | 1.24B | 199.27M | 19.06% |
| Dec 31, 2022 | 1.05B | 34.84M | 3.45% |
| Dec 31, 2021 | 1.01B | 148.18M | 17.18% |
| Dec 31, 2020 | 862.46M | -92.64M | -9.70% |
| Dec 31, 2019 | 955.10M | 95.46M | 11.11% |
| Dec 31, 2018 | 859.63M | 63.24M | 7.94% |
| Dec 31, 2017 | 796.39M | 32.87M | 4.31% |
| Dec 31, 2016 | 763.52M | 44.35M | 6.17% |
| Dec 31, 2015 | 719.17M | -20.89M | -2.82% |
| Dec 31, 2014 | 740.06M | -22.65M | -2.97% |
| Dec 31, 2013 | 762.70M | -4.44M | -0.58% |
| Dec 31, 2012 | 767.14M | 42.06M | 5.80% |
| Dec 31, 2011 | 725.08M | 11.35M | 1.59% |
| Dec 31, 2010 | 713.72M | 18.98M | 2.73% |
| Dec 31, 2009 | 694.74M | -47.44M | -6.39% |
| Dec 31, 2008 | 742.18M | 47.90M | 6.90% |
| Dec 31, 2007 | 694.29M | 47.48M | 7.34% |
| Dec 31, 2006 | 646.81M | 29.51M | 4.78% |
| Dec 31, 2005 | 617.31M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Enovis | 2.31B |
| Integra LifeSciences Holdings | 1.66B |
| Tandem Diabetes Care | 1.08B |
| Lumexa Imaging Holdings | 1.06B |
| Inspire Medical Systems | 880.94M |
| NovoCure | 725.39M |
| PROCEPT BioRobotics | 352.31M |
| Establishment Labs Holdings | 264.03M |
CNMD News
- 10 days ago - CONMED Corporation to Participate in the Jefferies Global Healthcare Conference - Business Wire
- 15 days ago - Conmed price target raised to $50 from $45 at JPMorgan - TheFly
- 15 days ago - Conmed reports Q3 EPS $1.04, consensus $1.00 - TheFly
- 15 days ago - Conmed raises FY26 EPS view to $4.54-$4.61 from $4.48-$4.60, consensus $4.54 - TheFly
- 15 days ago - CONMED Earnings Call Transcript: Q3 2026 - Transcripts
- 15 days ago - CONMED Earnings release: Q3 2026 - Filings
- 15 days ago - CONMED Quarterly report: Q3 2026 - Filings
- 15 days ago - CONMED Slides: Q3 2026 - Filings